These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27194993)

  • 1. Assessing the Relationship of Angiotensin II Type 1 Receptors with Erythropoietin in a Human Model of Endogenous Angiotensin II Type 1 Receptor Antagonism.
    Calò LA; Davis PA; Maiolino G; Pagnin E; Ravarotto V; Naso E; Carraro G; Naso A
    Cardiorenal Med; 2015 Dec; 6(1):16-24. PubMed ID: 27194993
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II signaling via type 2 receptors in a human model of vascular hyporeactivity: implications for hypertension.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Hypertens; 2010 Jan; 28(1):111-8. PubMed ID: 19797979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress-related factors in Bartter's and Gitelman's syndromes: relevance for angiotensin II signalling.
    Calò LA; Pagnin E; Davis PA; Sartori M; Semplicini A
    Nephrol Dial Transplant; 2003 Aug; 18(8):1518-25. PubMed ID: 12897089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between NOX4 level and angiotensin II signaling in Gitelman's syndrome. Implications with hypertension.
    Calò LA; Savoia C; Davis PA; Pagnin E; Ravarotto V; Maiolino G
    Int J Clin Exp Med; 2015; 8(5):7487-96. PubMed ID: 26221292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High angiotensin II state without cardiac remodeling (Bartter's and Gitelman's syndromes): are angiotensin II type 2 receptors involved?
    Calò LA; Montisci R; Scognamiglio R; Davis PA; Pagnin E; Schiavo S; Mormino P; Semplicini A; Palatini P; D'Angelo A; Pessina AC
    J Endocrinol Invest; 2009 Nov; 32(10):832-6. PubMed ID: 19605975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRT1, heme oxygenase-1 and NO-mediated vasodilation in a human model of endogenous angiotensin II type 1 receptor antagonism: implications for hypertension.
    Davis PA; Pagnin E; Dal Maso L; Caielli P; Maiolino G; Fusaro M; Paolo Rossi G; Calò LA
    Hypertens Res; 2013 Oct; 36(10):873-8. PubMed ID: 23698802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling.
    Calò LA; Facco M; Davis PA; Pagnin E; Maso LD; Puato M; Caielli P; Agostini C; Pessina AC
    Hypertens Res; 2011 Sep; 34(9):1017-22. PubMed ID: 21654754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of vascular remodelling in a high angiotensin-II state (Bartter's and Gitelman's syndromes): implications for angiotensin II signalling pathways.
    Calò LA; Puato M; Schiavo S; Zanardo M; Tirrito C; Pagnin E; Balbi G; Davis PA; Palatini P; Pauletto P
    Nephrol Dial Transplant; 2008 Sep; 23(9):2804-9. PubMed ID: 18344243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rho kinase and PAI-1 in Bartter's/Gitelman's syndromes: relationship to angiotensin II signaling.
    Pagnin E; Davis PA; Sartori M; Semplicini A; Pessina AC; Calò LA
    J Hypertens; 2004 Oct; 22(10):1963-9. PubMed ID: 15361768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing regulator of G protein signaling-2 (RGS-2) increases angiotensin II signaling: insights into hypertension from findings in Bartter's/Gitelman's syndromes.
    Calò LA; Pagnin E; Ceolotto G; Davis PA; Schiavo S; Papparella I; Semplicini A; Pessina AC
    J Hypertens; 2008 May; 26(5):938-45. PubMed ID: 18398336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early markers of inflammation in a high angiotensin II state--results of studies in Bartter's/Gitelman's syndromes.
    Davis PA; Mussap M; Pagnin E; Bertipaglia L; Savica V; Semplicini A; Calò LA
    Nephrol Dial Transplant; 2006 Jun; 21(6):1697-701. PubMed ID: 16574683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE2 and SARS-CoV-2 Infection Risk: Insights From Patients With Two Rare Genetic Tubulopathies, Gitelman's and Bartter's Syndromes.
    Calò LA; Rigato M; Sgarabotto L; Gianesello L; Bertoldi G; Ravarotto V; Davis PA
    Front Med (Lausanne); 2021; 8():647319. PubMed ID: 34017843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythropoietin alleviates post-resuscitation myocardial dysfunction in rats potentially through increasing the expression of angiotensin II receptor type 2 in myocardial tissues.
    Zhou H; Huang J; Zhu L; Cao Y
    Mol Med Rep; 2018 Apr; 17(4):5184-5192. PubMed ID: 29393490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased RBP4 in a human model of activated anti-atherosclerotic and antiremodelling defences.
    Calò LA; Maiolino G; Pagnin E; Vertolli U; Davis PA
    Eur J Clin Invest; 2014 Jun; 44(6):567-72. PubMed ID: 24739026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased expression of regulator of G protein signaling-2 (RGS-2) in Bartter's/Gitelman's syndrome. A role in the control of vascular tone and implication for hypertension.
    Calò LA; Pagnin E; Davis PA; Sartori M; Ceolotto G; Pessina AC; Semplicini A
    J Clin Endocrinol Metab; 2004 Aug; 89(8):4153-7. PubMed ID: 15292363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of erythropoietin regulation by angiotensin II.
    Kim YC; Mungunsukh O; McCart EA; Roehrich PJ; Yee DK; Day RM
    Mol Pharmacol; 2014 Jun; 85(6):898-908. PubMed ID: 24695083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced mRNA and protein content of rho guanine nucleotide exchange factor (RhoGEF) in Bartter's and Gitelman's syndromes: relevance for the pathophysiology of hypertension.
    Pagnin E; Semplicini A; Sartori M; Pessina AC; Calò LA
    Am J Hypertens; 2005 Sep; 18(9 Pt 1):1200-5. PubMed ID: 16182110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients.
    Calò LA; Davis PA; Pagnin E; Dal Maso L; Maiolino G; Seccia TM; Pessina AC; Rossi GP
    J Hypertens; 2014 Feb; 32(2):331-8. PubMed ID: 24356540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway.
    Gossmann J; Burkhardt R; Harder S; Lenz T; Sedlmeyer A; Klinkhardt U; Geiger H; Scheuermann EH
    Kidney Int; 2001 Jul; 60(1):83-6. PubMed ID: 11422739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: pathophysiological implications.
    Calò LA; Schiavo S; Davis PA; Pagnin E; Mormino P; D'Angelo A; Pessina AC
    J Nephrol; 2010; 23(4):472-7. PubMed ID: 20349406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.